Abbreviations
- ACE:
-
Angiotensin-converting enzyme
- FiO2 :
-
Fraction of inspired oxygen
- HES:
-
Hydroxyethyl starch
- NaCl:
-
odium chloride
- NSAID:
-
Nonsteroidal anti inflammatory drugs
References
Johansson SG, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF et al. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004; 113: 832–836
Ring J, Grosber M, Mührenschlager M, Brockow K. Anaphylaxis: acute treatment and management. Chem Immunol Allergy 2010; 95: 201–10
Simons FE, Ardusso LR, Bilo MB, El-Gamal YM, Ledford DK, Ring J et al. World Allergy Organization anaphylaxis guidelines: summary. J Allergy Clin Immunol 2011; 127: 587–593.e1-22
Tryba M, Ahnefeld F, Barth J, Dick W, Doenicke A, Fuchs T et al. Akuttherapie anaphylaktoider Reaktionen. Ergebnisse einer interdisziplinären Konsensuskonferenz. Allergo J 1994; 3: 211–222
Ring J, Brockow K, Duda D, Eschenhagen T, Fuchs Th, Huttegger I et al. Emergency treatment of anaphylactic reactions. Allergo J 2007; 16: 420–434
Bresser H, Sander CH, Rakoski J. Emergencies by insect stings in Munich in 1992. Allergo J 1995; 4: 373–376
Mehl A, Wahn U, Niggemann B. Anaphylactic reactions in children — a questionnaire-based survey in Germany. Allergy 2005; 60: 1440–1445
Portier P, Richet C. De l’action anaphylactique de certains venins. C R Soc Biol 1902; 54: 170
Sampson HA, Munoz-Furlong A, Campbell RL, Adkinson NF Jr, Bock SA, Branum A et al. Second symposium on the definition and management of anaphylaxis: summary report — Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 2006; 117: 391–397
Worm M. Epidemiology of anaphylaxis. Chem Immunol Allergy 2010; 95: 12–21
Moneret-Vautrin DA, Morisset M, Flabbee J, Beaudouin E, Kanny G. Epidemiology of life-threatening and lethal anaphylaxis: a review. Allergy 2005; 60: 443–451
Helbling A, Hurni T, Mueller UR, Pichler WJ. Incidence of anaphylaxis with circulatory symptoms: a study over a 3-year period comprising 940,000 inhabitants of the Swiss Canton Bern. Clin Exp Allergy 2004; 34: 285–290
Decker WW, Campbell RL, Manivannan V, Luke A, St Sauver JL, Weaver A et al. The etiology and incidence of anaphylaxis in Rochester, Minnesota: a report from the Rochester Epidemiology Project. J Allergy Clin Immunol 2008; 122: 1161–1165
Sheikh A, Hippisley-Cox J, Newton J, Fenty J. Trends in national incidence, lifetime prevalence and adrenaline prescribing for anaphylaxis in England. J R Soc Med 2008; 101: 139–143
Poulos LM, Waters AM, Correll PK, Loblay RH, Marks GB. Trends in hospitalizations for anaphylaxis, angioedema, and urticaria in Australia, 1993–1994 to 2004–2005. J Allergy Clin Immunol 2007; 120: 878–884
Worm M, Edenharter G, Rueff F, Scherer K, Pföhler C, Mahler V et al. Symptom profile and risk factors of anaphylaxis in Central Europe. Allergy 2012; 67: 691–698
Smith PL, Kagey-Sobotka A, Bleecker ER, Traystman R, Kaplan AP, Gralnick H et al. Physiologic manifestations of human anaphylaxis. J Clin Invest 1980; 66: 1072–1080
Vadas P, Perelman B, Liss G. Platelet-activating factor, histamine, and tryptase levels in human anaphylaxis. J Allergy Clin Immunol 2013; 131: 144–149
Lee JK, Vadas P. Anaphylaxis: mechanisms and management. Clin Exp Allergy 2011; 41: 923–938
Ring J. Angewandte Allergologie. München: Urban & Vogel 2004
Rueff F, Przybilla B, Bilo MB, Müller U, Scheipl F, Aberer W et al. Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity. J Allergy Clin Immunol 2009; 124: 1047–1054
Brockow K, Jofer C, Behrendt H, Ring J. Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients. Allergy 2008; 63: 226–232
Guenova E, Volz T, Eichner M, Hoetzenecker W, Caroli U, Griesinger G et al. Basal serum tryptase as risk assessment for severe Hymenoptera sting reactions in elderly. Allergy 2010; 65: 919–923
Przybilla B, Ruëff F, Walker B, Räwer HC, Aberer W, Bauer CP et al. Diagnosis and therapy of bee and wasp venom allergy. Allergo J 2011; 20: 318–339
Muraro A, Roberts G, Clark A, Eigenmann PA, Halken S, Lack G et al. The management of anaphylaxis in childhood: position paper of the European academy of allergology and clinical immunology. Allergy 2007; 62: 857–871
Ring J, Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet 1977; 1: 466–469
Stark BJ, Sullivan TJ. Biphasic and protracted anaphylaxis. J Allergy Clin Immunol 1986; 78: 76–83
Commins SP, Platts-Mills TA. Anaphylaxis syndromes related to a new mammalian cross-reactive carbohydrate determinant. J Allergy Clin Immunol 2009; 124: 652–657
Barnard JH. Studies of 400 Hymenoptera sting deaths in the United States. J Allergy Clin Immunol 1973; 52: 259–264
Delage C, Irey NS. Anaphylactic deaths: a clinicopathologic study of 43 cases. J Forensic Sci 1972; 17: 525–540
Fisher MM. Clinical observations on the pathophysiology and treatment of anaphylactic cardiovascular collapse. Anaesth Intensive Care 1986; 14: 17–21
Pumphrey RS, Roberts IS. Postmortem findings after fatal anaphylactic reactions. J Clin Pathol 2000; 53: 273–276
Krogh G von, Maibach HI. The contact urticaria syndrome — an updated review. J Am Acad Dermatol 1981; 5: 328–342
Kemp SF, Lockey RF. Anaphylaxis: a review of causes and mechanisms. J Allergy Clin Immunol 2002; 110: 341–348
Morita E, Kunie K, Matsuo H. Food-dependent exercise-induced anaphylaxis. J Dermatol Sci 2007; 47: 109–117
Pumphrey RS. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy 2000; 30: 1144–1150
Mullins RJ, Dear KB, Tang ML. Characteristics of childhood peanut allergy in the Australian Capital Territory, 1995 to 2007. J Allergy Clin Immunol 2009; 123: 689–693
Schwartz LB. Clinical utility of tryptase levels in systemic mastocytosis and associated hematologic disorders. Leuk Res 2001; 25: 553–562
Brockow K, Vieluf D, Püschel K, Grosch J, Ring J. Increased postmortem serum mast cell tryptase in a fatal anaphylactoid reaction to nonionic radiocontrast medium. J Allergy Clin Immunol 1999; 104: 237–238
Nolan JP, Soar J, Zideman DA, Biarent D, Bossaert LL, Deakin C et al. European Resuscitation Council Guidelines for Resuscitation 2010 Section 1. Executive summary. Resuscitation 2010; 81: 1219–1276
Thomas M, Crawford I. Best evidence topic report. Glucagon infusion in refractory anaphylactic shock in patients on beta-blockers. Emerg Med J 2005; 22: 272–273
Simons FE, Schatz M. Anaphylaxis during pregnancy. J Allergy Clin Immunol 2012; 130: 597–606
Bellomo R, Chapman M, Finfer S, Hickling K, Myburgh J. Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet 2000; 356: 2139–2143
Friedrich JO, Adhikari N, Herridge MS, Beyene J. Meta-analysis: low-dose dopamine increases urine output but does not prevent renal dysfunction or death. Ann Intern Med 2005; 142: 510–524
Gronemeyer. Noradrenalin statt Adrenalin beim anaphylaktischen Schock. Dtsch Med Wochenschr 1980, 102: 101
Hoffmann BB. Catecholamines, sympathomimetic drugs and adrenergic receptor anatagonists. In: Hardman JG, Limbird LE, Goodman A, eds. Goodman & Gilman’s. The pharmaceutical basis of therapeutics.NewYork: Mc Graw Hill, 2002
Schummer C, Wirsing M, Schummer W. The pivotal role of vasopressin in refractory anaphylactic shock. Anesth Analg 2008; 107: 620–624
Meßmer K. Plasma substitutes and indications for their use. In: Tinker J, Rapin M, eds. Care of the critically ill patient. Berlin — Heidelberg — New York: Springer, 1983. S. 569–575
Stölting RK: Systemic circulation. Pharmacology & physiology in anesthetic practice. Philadelphia: J.B. Lippincott Company, 2006. S. 661–678
Walther A, Böttiger BW: Anaphylaktoide Reaktionen in der Prähospitalphase. Internist 2004; 45: 296–304
Vincent JL, De Backer D. Circulatory shock. N Engl J Med 2013; 369: 1726–1734
Martin C, Jacob M, Vicaut E, Guidet B, Van Aken H, Kurz A. Effect of waxy maize-derived hydroxyethyl starch 130/0.4 on renal function in surgical patients. Anesthesiology 2013; 118: 387–394
Myburgh JA, Finfer S, Bellomo R, Billot L, Cass A, Gattas D. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012; 367: 1901–1911
Sheikh A, Ten Broek V, Brown SG, Simons FE. H1-antihistamines for the treatment of anaphylaxis: Cochrane systematic review. Allergy 2007; 62: 830–837
Zuberbier T, Asero R, Bindslev-Jensen C, Walter Canonica G, Church MK, Giménez-Arnau AM et al. EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria. Allergy 2009; 64: 1427–1443
Pragst F, Herre S, Bakdash A. Poisonings with diphenhydramine — a survey of 68 clinical and 55 death cases. Forensic Sci Int 2006; 161: 189–197
Lin RY, Curry A, Pesola GR, Knight RJ, Lee HS, Bakalchuk L et al. Improved outcomes in patients with acute allergic syndromes who are treated with combined H1 and H2 antagonists. Ann Emerg Med 2000; 36: 462–468
Ring J, Rothenberger KH, Clauss W. Prevention of anaphylactoid reactions after radiographic contrast media infusion by combined histamine H1- and H2-receptor antagonists: results of a prospective controlled trial. Int Arch Allergy Appl Immunol 1985; 78: 9–14
Brockow K, Kiehn M, Riethmüller C, Vieluf D, Berger J, Ring J. Efficacy of antihistamine pretreatment in the prevention of adverse reactions to Hymenoptera immunotherapy: a prospective, randomized, placebo-controlled trial. J Allergy Clin Immunol 1997; 100: 458–463
Aouam K, Bouida W, Ben Fredj N, Chaabane A, Boubaker H, Boukef R et al. Severe ranitidine-induced anaphylaxis: a case report and literature review. J Clin Pharm Ther 2012; 37: 494–496
Winbery SL, Lieberman PL. Histamine and antihistamines in anaphylaxis. Clin Allergy Immunol 2002; 17: 287–317
Choo KJ, Simons E, Sheikh A. Glucocorticoids for the treatment of anaphylaxis: Cochrane systematic review. Allergy 2010; 65: 1205–1211
Fischer J, Biedermann T. Anaphylaxis due to allergological testing or therapy — a compact compendium for emergency management Allergo J 2009; 18: 124–131
Bundesärztekammer (BÄK), Kassenärztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF). Nationale Versorgungsleitlinie Asthma — Langfassung, 2. Aufl. Version 5. 2009, zuletzt geändert: August 2013 [cited: 26.02.2014]; http://www.versorgungsleitlinien.de/themen/asthma
Hartmann K, Biedermann T, Brockow K, Grabbe J, Horny H-P, Lippert U et al. Mastocytosis. Guideline of the German Society for Allergology an Clinical Immunology (DGAKI) and the German Society for Dermatology (DDG). Allergo J 2009; 18: 196–207
Simons FE, Ardusso LR, Dimov V, Ebisawa M, El-Gamal YM, Lockey RF et al. World Allergy Organization Anaphylaxis Guidelines: 2013 update of the evidence base. Int Arch Allergy Immunol 2013; 162: 193–204
Lieberman JA, Chehade M. Use of omalizumab in the treatment of food allergy and anaphylaxis. Curr Allergy Asthma Rep 2013; 13: 78–84
Ring J, Beyer K, Dorsch A, Biedermann T, Fischer J, Friedrichs F et al. Anaphylaxis school — a new educational program for tertiary prevention in patients with anaphylaxis. Allergo J 2012; 21: 96–102
Fischer J, Kupfer J, Grosber M, Friedl T, Schallmeyer S, Rueff F, et al. Practical skills in the self therapy of anaphylaxis — development and evaluation of a test on decision making and prctical performance. Allergo J 2013; 22: 18–24
Author information
Authors and Affiliations
Corresponding author
Additional information
Cite this as: Ring J, Beyer K, Biedermann T, Bircher A, Duda D, Fischer J et al. Guideline for acute therapy and management of anaphylaxis — S2 Guideline of DGAKI, AeDA, GPA, DAAU, BVKJ, ÖGAI, SGAI, DGAI, DGP, DGPM, AGATE and DAAB. Allergo J Int 2014; 23: 96–112 DOI 10.1007/s40629-014-0009-1
Conflict of Interest
The authors declare that there is no conflict of interest. More detailed information can be seen on the AWMF website (www.awmf.org).
Rights and permissions
About this article
Cite this article
Ring, J., Beyer, K., Biedermann, T. et al. Guideline for acute therapy and management of anaphylaxis. Allergo J Int 23, 96–112 (2014). https://doi.org/10.1007/s40629-014-0009-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40629-014-0009-1